Morgantown-based Protea Biosciences Group is expanding into a new 11,000-square-foot facility in Morgantown. The firm plans to expand its current mass spectrometry services to the biopharma market. The new space will provide more room for instrumentation and analytical capabilities, including the use of the company's LAESI DP-1000 system for distribution profiling of biomolecules. The facility is expected to be operational by the end of April 2012. Protea is a leader in the field of bioanalytics, the identification and characterization of proteins, metabolites and other biomolecules.
Read recent or past issues of West Virginia's Open For Business Report